Quinapril

Quinapril

SCHEMBL11286555

CCOC(=O)[C@H](CCc1ccccc1)N[C@H](C)C(=O)N1Cc2ccccc2CC1C(=O)O

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ACE

The experimentally established mechanism targets of Quinapril. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 5)

geneUniProtsupporting neighboursconfidence
ACE known ✓ P12821 16/20 1.00
ABCB11 O95342 2/20 1.00
PDE3A Q14432 1/20 0.80
LMNA P02545 1/20 0.70
SMN1; SMN2 Q16637 1/20 0.65

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Quinapril SCHEMBL15813 1.00 ACE (1.00) ACEABCB11PDE3ALMNASMN1; SMN2
Quinapril SCHEMBL13575806 1.00 ACE (1.00) ACEABCB11PDE3ALMNASMN1; SMN2
Quinapril SCHEMBL29380303 1.00 ACE (1.00) ACEABCB11PDE3ALMNASMN1; SMN2
Quinapril SCHEMBL29846170 1.00 ACE (1.00) ACEABCB11PDE3ALMNASMN1; SMN2
Quinapril SCHEMBL678447 1.00 ACE (1.00) ACEABCB11PDE3ALMNASMN1; SMN2
Quinapril SCHEMBL11294979 1.00 ACE (1.00) ACEABCB11PDE3ALMNASMN1; SMN2
Quinapril SCHEMBL19361887 1.00 ACE (1.00) ACEABCB11PDE3ALMNASMN1; SMN2
Quinapril SCHEMBL994608 1.00 ACE (1.00) ACEABCB11PDE3ALMNASMN1; SMN2
Quinapril SCHEMBL9094436 1.00 ACE (1.00) ACEABCB11PDE3ALMNASMN1; SMN2
Quinapril SCHEMBL11286551 1.00 ACE (1.00) ACEABCB11PDE3ALMNASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0065301-A1 Isoquinoline carboxylic acid derivates, process for preparing and pharmaceutical composition containing the same MERCK & CO. INC. (US) 1982-11-24 EP claimed